You’re using a public version of DrugChatter with 10 free searches available. Register to unlock more free searches per day. CREATE FREE ACCOUNT

Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.


Are there any known contraindications with cosentyx?

See the DrugPatentWatch profile for cosentyx

Cosentyx Contraindications: What You Need to Know

Cosentyx, a biologic medication used to treat various autoimmune diseases, including psoriasis, psoriatic arthritis, and ankylosing spondylitis, has a range of contraindications that healthcare providers and patients should be aware of.


According to the FDA-approved label, Cosentyx is contraindicated in patients with a history of hypersensitivity to certolizumab pegol or any of its components. Additionally, patients with active tuberculosis (TB) or those with a history of TB who have not received appropriate treatment are also contraindicated from receiving Cosentyx.

Important Considerations

It is essential to note that Cosentyx is not recommended for use in patients with a history of lymphoma or other malignancies. Patients with a history of demyelinating disorders, such as multiple sclerosis, should also be closely monitored while receiving Cosentyx, as there is a risk of exacerbation.

Special Populations

Pregnant women should not receive Cosentyx, as there is a risk of fetal harm. Breastfeeding women should also avoid using Cosentyx, as it is not known whether the medication is excreted in human milk.

Interactions and Warnings

Cosentyx may interact with other medications, including immunosuppressants, which may increase the risk of infections. Patients receiving Cosentyx should also be monitored for signs of hypersensitivity reactions, including anaphylaxis.


"Cosentyx is a potent biologic agent that has been shown to be effective in treating various autoimmune diseases. However, it is essential to carefully consider the contraindications and warnings associated with its use, as outlined in the FDA-approved label." -


1. FDA. (2020). Cosentyx (certolizumab pegol) Prescribing Information.
2. (2020). Cosentyx (certolizumab pegol) Patent Expiration.
3. UCB. (2020). Cosentyx (certolizumab pegol) Product Information.

Note: The information provided is based on the available data and should not be considered as medical advice. It is essential to consult with a healthcare provider for personalized guidance on the use of Cosentyx.

Other Questions About Cosentyx :  Have there been any reported adverse effects in elderly patients using cosentyx? How does cosentyx affect the immune system over time? Are there any risks in getting a flu shot post cosentyx?

DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2024. All rights reserved. Privacy